E-LIB Suche - Ergebnisse für: Levy, Gallia

1

Pictilisib for oestrogen receptor-positive, aromatase inhib..:

Krop, Ian E ; Mayer, Ingrid A ; Ganju, Vinod...
The Lancet Oncology. 17 (2016) 6 - p. 811-821 , 2016

2

Cloning and Characterization of zRICH, a 2′,3′‐Cyclic‐Nucle..:

Ballestero, Rafael P. ; Dybowski, Joseph A. ; Levy, Gallia..
Journal of Neurochemistry. 72 (1999) 4 - p. 1362-1371 , 1999

Link: https://doi.org/10.1046/..

3

The autosomal recessive isolated deafness, DFNB2, and the U..:

Weil, Dominique ; Küssel, Polonca ; Blanchard, Stéphane...
Nature Genetics. 16 (1997) 2 - p. 191-193 , 1997

Link: https://doi.org/10.1038/..

4

Human Myosin VIIA Responsible for the Usher 1B Syndrome: A ..:

Weil, Dominique ; Lévy, Gallia ; Sahly, Iman...
Proceedings of the National Academy of Sciences of the United States of America. 93 (1996) 8 - p. 3232-3237 , 1996

Link: https://www.jstor.org/st..

5

Syndrome de Usher de type IB : Anomalie d'une myosine non c..:

Weil, Dominique ; Levy, Gallia ; Sahly, Iman...
Annales de l'Institut Pasteur / Actualités. 6 (1995) 4 - p. 300-303 , 1995

Link: https://doi.org/10.1016/..

6

Untreated bleeds in people with hemophilia A in a noninterv..:

Callaghan, Michael U. ; Asikanius, Elina ; Lehle, Michaela...
Research and Practice in Thrombosis and Haemostasis. 6 (2022) 6 - p. e12782 , 2022

Link: https://doi.org/10.1002/..

7

Effect of emicizumab prophylaxis on bone and joint health m..:

Kiialainen, Anna ; Niggli, Markus ; Kempton, Christine L....
Haemophilia. 28 (2022) 6 - p. 1033-1043 , 2022

Link: https://doi.org/10.1111/..

8

The effect of emicizumab prophylaxis on long‐term, self‐rep..:

Skinner, Mark W. ; Négrier, Claude ; Paz‐Priel, Ido...
Haemophilia. 27 (2021) 5 - p. 854-865 , 2021

Link: https://doi.org/10.1111/..

9

A Model‐Based Framework to Inform the Dose Selection and St..:

Yoneyama, Koichiro ; Schmitt, Christophe ; Chang, Tiffany...
The Journal of Clinical Pharmacology. 62 (2021) 2 - p. 232-244 , 2021

Link: https://doi.org/10.1002/..

10

Pharmacokinetics and Pharmacodynamics of Emicizumab in Pers..:

Schmitt, Christophe ; Adamkewicz, Joanne I. ; Xu, Jin...
Thrombosis and Haemostasis. 121 (2020) 3 - p. 351-360 , 2020

Link: https://doi.org/10.1055/..

11

A phase 2 PK/PD study of andexanet alfa for reversal of riv..:

Curnutte, John T. ; Crowther, Mark ; Castillo, Janice...
Blood Advances. 4 (2020) 4 - p. 728-739 , 2020

Link: https://doi.org/10.1182/..

12

Outcomes in children with hemophilia A with inhibitors: Res..:

Oldenburg, Johannes ; Shima, Midori ; Kruse‐Jarres, Rebecca...
Pediatric Blood & Cancer. 67 (2020) 10 - p. , 2020

Link: https://doi.org/10.1002/..

13

Health‐related quality of life and health status in persons..:

Mahlangu, Johnny ; Oldenburg, Johannes ; Callaghan, Michael U....
Haemophilia. 25 (2019) 3 - p. 382-391 , 2019

Link: https://doi.org/10.1111/..

14

Safety analysis ofrFVIIa with emicizumab dosing in congenit..:

Levy, Gallia G. ; Asikanius, Elina ; Kuebler, Peter...
Journal of Thrombosis and Haemostasis. 17 (2019) 9 - p. 1470-1477 , 2019

Link: https://doi.org/10.1111/..

15

Bleeding events and safety outcomes in persons with haemoph..:

Mahlangu, Johnny ; Oldenburg, Johannes ; Callaghan, Michael U....
Haemophilia. 24 (2018) 6 - p. 921-929 , 2018

Link: https://doi.org/10.1111/..